Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Anesthesiology. 2016 Aug;125(2):333–345. doi: 10.1097/ALN.0000000000001199

Table 1.

Bacteria reverse mutation assay (Ames test) for Calabadion 2, in the presence or absence of rat liver S9 fraction (−/+S9) in order to test for metabolic activation. Displayed are numbers of colonies growing after treatment with the test compound (Data are ± SD) and the ratio of the number of colonies growing after treatment with the test compound relative to untreated bacteria.

TA 1535 TA 1537 TA 98 TA 100
Calabadion 2 concentration (mg) −S9 +S9 −S9 + S9 −S9 + S9 −S9 + S9
0 11 ± 2 8 ± 2 10 ± 5 7 ± 1 19 ± 2 27 ± 3 100 ± 27 109 ± 4
0.012 6 ± 1 10 ± 2 7 ± 2 2 ± 1 24 ± 4 24 ± 4 92 ± 11 114 ± 2
0.037 10 ± 5 6 ± 2 8 ± 2 4 ± 1 18 ± 8 27 ± 3 100 ± 6 112 ± 8
0.11 8 ± 3 7 ± 1 7 ± 2 6 ± 1 30 ± 10 23 ± 5 94 ± 4 91 ± 6
0.33 7 ± 4 10 ± 5 8 ± 1 6 ± 1 21 ± 5 24 ± 7 105 ± 9 101 ± 7
1 8 ± 3 7 ± 3 3 ± 2 5 ± 2 20 ± 5 29 ± 6 106 ± 6 97 ± 4
Ratio 0.72 0.87 0.3 0.71 1.05 1.07 1.06 0.88
Positive Control SA
446
2-AA
91
191-A
250
2-AA
141
D-myc
505
2-AA
1101
SA
282
2-AA
1307

191-A = ICR 191 Acridine; 2-AA = 2-Aminoanthracene; D-myc = Daunomycin; SA = Sodium Azide; TA 98-1535=Strain number of Salmonella thyphimurium